In fact, PSMA-PET should be conducted for each patient before prostate biopsy to perform PSMA-TB to improve the diagnostic accuracy of PSMA-PET for clinically significant prostate cancer (csPCa) 17. The gene discussed is FOLH1; the disease is prostate cancer.